| Date Posted |
Subject |
| Oct. 28, 2011 |
Performing anemia investigation tests post transfusion |
| June 2, 2011 |
Thromboelastography Test (TEG® v ROTEM®)- Any Value for Assessing Hemostasis During Surgery? Another look… ADDENDA July 5 |
| May 19, 2011 |
Therapeutic Phlebotomy for Testosterone Replacement? |
| Sept. 30, 2010 |
How many units of Cell Saver are too many? |
| Jan. 10, 2010 |
Post blood donation seroma formation? ADDENDA Jan. 12 |
| Oct. 19, 2009 |
Risk of transfusion of blood products collected from donors who develop cancer |
| Mar.
5, 2009 |
Sources
for Purified Human Plasminogen? |
| Mar. 3, 2008 |
Treatment for severe plasma plasminogen deficiency complicated by a condition called ligneous conjunctivitis |
| Jan. 24, 2008 |
Handling
platelet transfusions requests for patients with intracranial bleeds
who are on Plavix® |
| Jan. 6, 2008 |
Does
tyramine remain in banked blood? ADDENDA Jan.
7 & 9 |
| Nov. 27, 2007 |
Induction of an inhibitor
antibody to factor XI in a patient with severe inherited factor XI
deficiency |
| Oct. 12, 2007 |
What
are expert thoughts about the recent articles on
Nitric Oxide and banked blood? |
| Sept. 17, 2007 |
Patient
'wallet card' text for HPA-1a antibodies ADDENDA Sept.
24 & Oct. 1 |
| Sept. 17, 2007 |
Practical
considerations when collecting "shed blood" into a disposable
system for blood reinfusion ADDENDA Sept.
17 & 21 |
| Apr. 25, 2007 |
Use of 'autologous serum eye drops' for patients with certain corneal disorders ADDENDA Apr. 27, May 2 & 4, June 1; Sept. 16, 2008 |
| Apr. 4, 2007 |
Enzymatic removal of group A and group B antigens: how close are we to a universal blood supply? |
| Apr. 4, 2007 |
Unexpected, severe, life-threatening hyperkalemia during liver transplantation ADDENDA Apr. 14 |
| Jan. 14, 2007 |
Strategies for transfusion support of a patient with TAR (Thrombocytopenia Absent Radius) Syndrome ADDENDA Jan. 24 |
| Oct. 30, 2006 |
Published guidelines and standardized use of fibrin sealants and topical hemostatic agents ADDENDA Oct. 31, 2006 |
| July 22, 2006 |
Marked changes in red cell antibody titers during continuous veno-venous hemodialysis ADDENDA Aug 7 |
| Apr. 21, 2006 |
Is it clinically useful to differentiate between various subgroups of A, such as A2, A3, and others, in the setting of renal transplantation? ADDENDA Aug. 3 & 9 |
| Feb. 7, 2006 |
Are colleagues modifying their practice over concerns about the risk associated with aprotinin in cardiac surgery? |
| Jan. 8, 2006 |
Is anyone using an intravenous Rh immune globulin preparation for the treatment of ITP that has not been approved by the FDA for that indication? ADDENDA Jan. 10, 11 & 13, 2006 |
| Nov. 15, 2005 |
Experience in the preparation of platelet gel, including for use in skin ulcer repair for Scleroderma |
| Sept. 23, 2005 |
The efficacy of aprotinin and the ethics of further Randomized Clinical Trials to assess that efficacy ADDENDA Nov. 29 |
| Sept. 9, 2005 |
Experience with the use of "amniopatch" treatment for Premature Prelabour Rupture of Membrane (PROM) ADDENDA Sept. 13 |
| Mar. 21, 2005 |
Suitability of patients with sickle cell disease for intraoperative cell salvage ADDENDA Mar. 23 |
| Feb. 6, 2005 |
What is the minimum safe platelet count prior to spinal anesthesia in the absence of thrombocytopathy? ADDENDA Feb. 8 & 10 |
| Feb. 23, 2004 |
Use of a 'blood patch' to treat severe headache due to cerebrospinal fluid leakage after epidural anesthesia ADDENDA Feb. 24, 25 & 26 |
| Jan. 22, 2004 |
Should surgical repair of hip fracture be delayed in patients who are receiving the anti-platelet drug Plavix? ADDENDA Jan. 25; Sept. 19, 2005 |
| July 22, 2003 |
Is the presence of ant-Jk(a) in a patient of concern when considering a living related kidney transplant from a donor who is Jk(a) positive? ADDENDA July 23 |
| May 22, 2003 |
How often should a patient with known IgA deficiency be retested for development of anti-IgA antibodies? ADDENDA May 23 |
| Jan. 18, 2003 |
Is it possible to administer IVIG (or IMIG) to an IgA-deficient patient with anti-IgA who has had a previous anaphylactic reaction to IVIG? ADDENDA Jan. 21, 22 & 29 |
| Jan. 5, 2003 |
In Jehovah's Witnesses with AML, what are the chances that intensive chemotherapy without blood component support will induce a sustained remission? |
| Sept. 7, 2002 |
Is Interleukin-11 of value in raising the platelet count in surgical patients (Jehovah's Witnesses) with thrombocytopenia? ADDENDA Sept. 11 & Nov. 15 |
| Mar. 21, 2002 |
Factor V inhibitors are a complication of bovine thrombin exposure |
| Feb. 26, 2001 |
Thromboelastography Test - Any Value for Assessing Hemostasis During Surgery? ADDENDA Feb. 27 & 28, 2001; June 11, 2008 |
| Feb. 25, 1999 |
Is yeast allergy an absolute contraindication to Hep B vaccination? |
